Company news
TrivarX Limited news in 2025
TrivarX Limited's news releases, calls and decks from 2025, newest first.
Positive results from US-veteran mental health trial
December 17, 2025
TRI Exercises Option to Advance Acquisition of Stabl-Im
November 4, 2025
September 2025 Quarterly Activities Report and Appendix 4C
October 30, 2025
US-veteran mental health trial patient recruitment complete
October 21, 2025
Acquisition of Stabl-Im technology and Private Placement
October 15, 2025
Reinstatement to Official Quotation
October 15, 2025
Extension of Trading Suspension
October 12, 2025
Suspension from Quotation
October 8, 2025
Inadvertent Lift of Trading Halt
October 8, 2025
Pause in trade
October 7, 2025
Positive interim results from US-veteran focused trial
October 7, 2025
Trading Halt
October 6, 2025
Appendix 4E - Preliminary Final Report
August 28, 2025
June 2025 Quarterly Activities Report and Appendix 4C
July 30, 2025
First patient recruited in innovative mental health trial
June 18, 2025
March 2025 Quarterly Activities Report and Appendix 4C
April 30, 2025
IRB approval for trial with US Dept of Veterans Affairs
April 27, 2025
TrivarX Receives Firm Commitments to Raise $2.25 million
March 16, 2025
Trial with US Department of Veterans Affairs
March 12, 2025
Appendix 4D & Half-Year Financial Report to 31 December 2024
February 28, 2025
December 2024 Quarterly Activities Report and Appendix 4C
January 30, 2025